Company Filing History:
1 out of 148 
1 out of 173 
1 out of 1,178 
Years Active: 2005-2024
Title: Kusumam Joseph: Innovator in Plasma Protease Research
Introduction
Kusumam Joseph is a notable inventor based in Mt. Pleasant, SC (US). He has made significant contributions to the field of medical research, particularly in the area of plasma protease and its implications for various disorders. With a total of 3 patents, his work has paved the way for advancements in diagnostic and treatment methodologies.
Latest Patents
Kusumam Joseph's latest patents focus on the evaluation, assays, and treatment of pKal-mediated disorders. One of his inventions provides assay methods for detecting plasma protease C1 inhibitor (C1-INH) that binds plasma kallikrein, Factor XII, or both. This invention is crucial for identifying subjects at risk for or suffering from pKal-mediated or bradykinin-mediated disorders. The methods he developed allow for the analysis of patients with plasma kallikrein-mediated angioedema (KMA) and other diseases mediated by pKal, which are useful in both evaluation and treatment.
Another significant patent by Joseph also centers on assays for determining levels of plasma protease C1 inhibitor. This invention similarly provides assay methods for detecting C1-INH and its binding to plasma kallikrein and Factor XII. The applications of these methods are vital for identifying at-risk patients and improving treatment strategies for related disorders.
Career Highlights
Throughout his career, Kusumam Joseph has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Nippon Zoki Pharmaceutical Co., Ltd. and Dyax Corporation. His experience in these organizations has contributed to his expertise in the field of plasma protease research.
Collaborations
Kusumam Joseph has collaborated with various professionals in his field. One of his notable coworkers is Allen P Kaplan, who has also made significant contributions to medical research.
Conclusion
Kusumam Joseph's innovative work in the field of plasma protease research has led to important advancements in the diagnosis and treatment of related disorders. His patents reflect a commitment to improving patient outcomes through scientific innovation.